Brean Murray Sees Recent Upside in Idenix (IDIX) Related to Possible Gilead (GILD) Settlement in June

Article Stock Quotes (2) Comments (0)

A late-day note from Brean Murray's Brian Skorney attributed strength in shares of Idenix Pharma (Nasdaq: IDIX) to a possible settlement with Gilead (Nasdaq: GILD) in June. The stock was up about 4.5 percent prior to the release of Skorney's note, however jumped over the $10 mark to close up more than 8 percent after the comments started getting passed around.

The analyst cited a public filing dated May 22nd and posted suggests "the two parties have recently discussed the possibility of settlement and are planning to have further discussion in June in an attempt to reach a settlement." Skorney believes a settlement could include "read-through to what economic rights, if any, Idenix may be entitled regarding Gilead's lead Hep C drug candidate..."

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Shorts Buried in MLM Companies (HLF) (USNA) (NUS)
• Despite Massive Moves in Solar Stocks, Boon Times are Cleary Not Here (FSLR) (JASO) (SCTY) (RSOL)
• UPDATE: JPMorgan Cuts SodaStream (SODA) to Neutral, 'Stock No Longer Cheap'

Create E-mail Alert Related Categories

Analyst Comments, Momentum Movers

Related Entities

Brean Murray Carret & Co.

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?